Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lenalidomide in Combination With Bendamustine and Rituximab for Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma(CLL/SLL): a Phase I Study

NCT01400685 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01400685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lenalidomide in Combination With Bendamustine and Rituximab for Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma(CLL/SLL): a Phase I Study
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
January 31, 2018
Enrollment
34 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

b chronic lymphocytic leukemia, chronic lymphocytic leukemia, small lymphocytic lymphoma